|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Mar 29, 2022 |
Title |
H9_HEP_Cont_12DAH_rep1 |
Sample type |
SRA |
|
|
Source name |
Hepatocyte-like cells derived from H9 human embryonic stem cells
|
Organism |
Homo sapiens |
Characteristics |
condition: 37degreeC derived tissue: Human hepatocyte-like cells time point: 12DAH
|
Treatment protocol |
On day 14, cells were incubated at 37or 39˚C, and half the total amount of the medium was changed every day.
|
Growth protocol |
Before inducing differentiation, we coated a cell-culture dish with 0.1% gelatin in phosphate-buffered saline (PBS, Thermo Fisher Scientific) for 30 min at 25˚C. We then aspirated the gelatin solution and introduced a DMEM/F12 medium (Sigma-Aldrich) onto the culture dish for serum coating at 37˚C for 24 h. The medium was supplemented with 10% (v/v) fetal bovine serum (Cell Culture Bioscience, Tokyo, Japan), penicillin/streptomycin (Wako), and 100 µM β-mercaptoethanol (Sigma-Aldrich). The coated dish was then rinsed with fresh medium. Cultured hPSCs were washed with PBS and treated with TryPLE Express at 37˚C for 5 min, followed by the addition of basal medium and the transfer of the cell suspension into a 15 mL tube to induce endoderm differentiation. Cells were centrifuged at 200 × g for 3 min, the supernatant was removed, and then the cells were resuspended in mTeSR-1 medium supplemented with 10 µM Y27632 and 100 ng mL−1 activin A (R&D Systems, Minneapolis, MN, USA), plated on a serum-coated culture dish, and cultured in a humidified incubator at 37˚C with 5% CO2 for 24 h. At the end of day 1, the medium was replaced with fresh mTeSR-1 medium supplemented with 10 µM Y27632 and 100 ng mL−1 activin A and cultured for another 24 h. On day 2, the medium was replaced with mTeSR-1 medium supplemented with 10 µM Y27632, 100 ng mL−1 activin A, 10 ng mL−1 BMP-4 (R&D Systems), 10 µM LY294002 (Cayman Chemical, Ann Arbor, MI, USA), and 3 µM CHIR99021 (Stemgent, Cambridge, MA, USA), and cells were incubated for 24 h. On day 3, the medium was replaced with mTeSR-1 medium supplemented with 10 µM Y27632, 100 ng mL−1 activin A, 10 ng mL−1 BMP-4, and 10 µM LY294002, and cells were incubated for 24 h. On day 4, the medium was replaced with Roswell Park Memorial Institute (RPMI) medium (Thermo Fisher Scientific) supplemented with B-27 (Thermo Fisher Scientific), 100 ng mL−1 activin A, and 100 ng mL−1 basic FGF, and cells were incubated for 24 h. To induce ADE specification, cells were treated with RPMI medium supplemented with 50 ng mL−1 activin A, with daily medium changes for three days. Cells were then treated with RPMI medium supplemented with 20 ng mL−1 BMP-4 and 10 ng mL−1 FGF-10 (R&D systems), with daily medium changes for four days. On day 12, the medium was replaced with hepatocyte-maturation medium (hepatocyte basal medium (Lonza, Basel, Switzerland) supplemented with 30 ng mL−1 oncostatin M (R&D Systems), 50 ng mL−1 HGF (PeproTech, Rocky Hill, NJ), and 25 mM HEPES (Wako) to induce maturation of the differentiated hepatocytes. On day 14, cells were incubated at 37, 39, or 42˚C, and half the total amount of the medium was changed every day.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted from hepatocyte-like cells derived from H9 human embryonic stem cells using the RNeasy mini kit (QIAGEN). To prepare the cDNA library, 10 ng of total RNA was diluted with 9 µL of RNase free water, then mixed with VN primer (Oxford NANOPORE Technologies, UK), 1 µL of 10 mM dNTPs (New England Biolabs Inc. Ipswich, Massachusetts, USA), and incubated at 65˚C for 5 min as the RNA solution. Separately, 4 µL of 5x RT Buffer (Thermo Fisher Scientific), 1 µL of RNaseOUT (Thermo Fisher Scientific), 1 µL of Nuclease-free water and 2 µL of Strand-Switching Primer (Oxford NANOPORE Technologies) was mixed as the strand-switching buffer. The two solutions were mixed at 42˚C for 2 min; then, 1 µL of Maxima H Minus Reverse Transcriptase (Thermo Fisher Scientific) was added, incubated at 42˚C for 90 min, 85˚C for 5 min, and stored at 4˚C until use as the cDNA library. Oxford NANOPORE Technologies Nanopore MinION Flowcell v.9.4.1.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
MinION |
|
|
Description |
mRNA-seq data from 37˚C-treated cells at 12DAH, replicate 1
|
Data processing |
Base-calling and demultiplexing were performed with EPI2ME software (Oxford NANOPORE Technologies). Failed reads were discarded and Fast5 files were converted into FASTQ and FASTA files using EPI2ME software. Generated FASTQ files were loaded to BioJupies for alignment with human genomes and annotation. the counts were analysed using TCC in R Bioconducter. Briefly, the counted data set was introduced into the TCC-GUI package. Genome_build: human_matrix.h5 v2 Supplementary_files_format_and_content: Gene counts were normalized using TMM (Trimmed mean of M values) methods in the edgeR package with the parameters: Number of Iterations = 3; FDR < 0.1; Elimination of Potential DEGs = 0.05.
|
|
|
Submission date |
Apr 16, 2021 |
Last update date |
Mar 29, 2022 |
Contact name |
Ken-ichiro Kamei |
E-mail(s) |
[email protected]
|
Phone |
+81-757539774
|
Organization name |
Kyoto University
|
Department |
iCeMS
|
Street address |
Yoshida-Ushinomiya-cho, Sakyo-ku
|
City |
Kyoto |
State/province |
Kyoto |
ZIP/Postal code |
6068501 |
Country |
Japan |
|
|
Platform ID |
GPL24106 |
Series (1) |
GSE172227 |
In vitro culture at 39° C during hepatic maturation of human ES cells facilitates hepatocyte-like cell functions |
|
Relations |
BioSample |
SAMN18758247 |
SRA |
SRX10615885 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|